1147 related articles for article (PubMed ID: 20546736)
21. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis.
De Stefano V; Martinelli I; Rossi E; Battaglioli T; Za T; Mannuccio Mannucci P; Leone G
Br J Haematol; 2006 Nov; 135(3):386-91. PubMed ID: 16984390
[TBL] [Abstract][Full Text] [Related]
22. Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study.
Le Gal G; Kovacs MJ; Carrier M; Do K; Kahn SR; Wells PS; Anderson DA; Chagnon I; Solymoss S; Crowther M; Righini M; Lacut K; White RH; Vickars L; Rodger M
Thromb Haemost; 2010 Sep; 104(3):498-503. PubMed ID: 20539910
[TBL] [Abstract][Full Text] [Related]
23. Overweight, obesity, and the risk of recurrent venous thromboembolism.
Eichinger S; Hron G; Bialonczyk C; Hirschl M; Minar E; Wagner O; Heinze G; Kyrle PA
Arch Intern Med; 2008 Aug; 168(15):1678-83. PubMed ID: 18695082
[TBL] [Abstract][Full Text] [Related]
24. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
Trujillo-Santos J; Nieto JA; Tiberio G; Piccioli A; Di Micco P; Prandoni P; Monreal M;
Thromb Haemost; 2008 Sep; 100(3):435-9. PubMed ID: 18766259
[TBL] [Abstract][Full Text] [Related]
25. The risk of recurrent venous thromboembolism in patients with and without factor V Leiden.
Eichinger S; Pabinger I; Stümpflen A; Hirschl M; Bialonczyk C; Schneider B; Mannhalter C; Minar E; Lechner K; Kyrle PA
Thromb Haemost; 1997 Apr; 77(4):624-8. PubMed ID: 9134632
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcome of patients with major bleeding after venous thromboembolism. Findings from the RIETE Registry.
Nieto JA; Camara T; Gonzalez-Higueras E; Ruiz-Gimenez N; Guijarro R; Marchena PJ; Monreal M;
Thromb Haemost; 2008 Nov; 100(5):789-96. PubMed ID: 18989522
[TBL] [Abstract][Full Text] [Related]
27. Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.
Prandoni P; Barbar S; Milan M; Campello E; Spiezia L; Piovella C; Pesavento R
Thromb Haemost; 2015 Jun; 113(6):1210-5. PubMed ID: 25119194
[TBL] [Abstract][Full Text] [Related]
28. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry.
Linnemann B; Zgouras D; Schindewolf M; Schwonberg J; Jarosch-Preusche M; Lindhoff-Last E
Blood Coagul Fibrinolysis; 2008 Mar; 19(2):159-65. PubMed ID: 18277138
[TBL] [Abstract][Full Text] [Related]
29. Venous thromboembolism in pregnancy.
James AH
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):326-31. PubMed ID: 19228606
[TBL] [Abstract][Full Text] [Related]
30. Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism.
Gulesserian T; Hron G; Endler G; Eichinger S; Wagner O; Kyrle PA
Thromb Haemost; 2006 Jan; 95(1):65-7. PubMed ID: 16543963
[TBL] [Abstract][Full Text] [Related]
31. Oral anticoagulant therapy in venous thromboembolism.
Cosmi B; Palareti G
Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
[TBL] [Abstract][Full Text] [Related]
32. Elevated white blood cell count and outcome in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
Trujillo-Santos J; Di Micco P; Iannuzzo M; Lecumberri R; Guijarro R; Madridano O; Monreal M;
Thromb Haemost; 2008 Nov; 100(5):905-11. PubMed ID: 18989537
[TBL] [Abstract][Full Text] [Related]
33. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients.
Nguyen GC; Sam J
Am J Gastroenterol; 2008 Sep; 103(9):2272-80. PubMed ID: 18684186
[TBL] [Abstract][Full Text] [Related]
34. Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study.
Glynn RJ; Ridker PM; Goldhaber SZ; Zee RY; Buring JE
Circulation; 2007 Sep; 116(13):1497-503. PubMed ID: 17846285
[TBL] [Abstract][Full Text] [Related]
35. Need for inferior vena cava filters in cancer patients: a surrogate marker for poor outcome.
Barginear MF; Lesser M; Akerman ML; Strakhan M; Shapira I; Bradley T; Budman DR
Clin Appl Thromb Hemost; 2009; 15(3):263-9. PubMed ID: 18385149
[TBL] [Abstract][Full Text] [Related]
36. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism.
Kyrle PA; Minar E; Hirschl M; Bialonczyk C; Stain M; Schneider B; Weltermann A; Speiser W; Lechner K; Eichinger S
N Engl J Med; 2000 Aug; 343(7):457-62. PubMed ID: 10950667
[TBL] [Abstract][Full Text] [Related]
37. Therapy insight: Vascular complications in patients with inflammatory bowel disease.
Koutroubakis IE
Nat Clin Pract Gastroenterol Hepatol; 2005 Jun; 2(6):266-72. PubMed ID: 16265230
[TBL] [Abstract][Full Text] [Related]
38. Impact and clinical significance of recurrent venous thromboembolism.
Labropoulos N; Spentzouris G; Gasparis AP; Meissner M
Br J Surg; 2010 Jul; 97(7):989-99. PubMed ID: 20632262
[TBL] [Abstract][Full Text] [Related]
39. Superficial thrombophlebitis and risk for recurrent venous thromboembolism.
Schönauer V; Kyrle PA; Weltermann A; Minar E; Bialonczyk C; Hirschl M; Quehenberger P; Schneider B; Partsch H; Eichinger S
J Vasc Surg; 2003 Apr; 37(4):834-8. PubMed ID: 12663985
[TBL] [Abstract][Full Text] [Related]
40. Anticoagulation period in idiopathic venous thromboembolism. How long is enough?
Farraj RS
Saudi Med J; 2004 Jul; 25(7):848-51. PubMed ID: 15235686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
